Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03406897 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
A Phase 1 study, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT03406897: Completed Phase 1 study, sponsored by Rodolfo Alejandro.
NCT03406897 is a Phase 1 study that has completed, run by Rodolfo Alejandro. The registered enrollment target is 27 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03406897, a Phase 1 study, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.
Primary Outcome
Stimulated (90-minute sample of a MMTT) C-peptide at the 1-year visit greater or equal to baseline level measured by ng/mL. Change in 90-minute C-peptide between baseline and 1-year visit
Interventions
- DRUG Cholecalciferol
- DRUG Omega 3 fatty acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 1 |
What the finished NCT03406897 record still lists
NCT03406897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT03406897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03406897 about?
NCT03406897 is a clinical study titled "Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients". The investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.
What is the current status of trial NCT03406897?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2018-07-23. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03406897?
The interventions under investigation include: Cholecalciferol (DRUG), Omega 3 fatty acid (DRUG).
Who is sponsoring clinical trial NCT03406897?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03406897's enrollment target sits among peer trials
27 1463rd of 2000 higher than 519 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI